CME Group Inc. (NASDAQ:CME) Shares Purchased by Greenleaf Trust

Greenleaf Trust lifted its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 219.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,142 shares of the financial services provider's stock after acquiring an additional 11,780 shares during the quarter. Greenleaf Trust's holdings in CME Group were worth $4,548,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in CME. SeaCrest Wealth Management LLC boosted its position in shares of CME Group by 3.0% during the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after buying an additional 40 shares during the last quarter. New Age Alpha Advisors LLC boosted its position in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares during the last quarter. Wealthcare Advisory Partners LLC boosted its position in shares of CME Group by 3.6% during the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock valued at $356,000 after buying an additional 47 shares during the last quarter. Koshinski Asset Management Inc. boosted its position in shares of CME Group by 1.4% during the first quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock valued at $934,000 after buying an additional 48 shares during the last quarter. Finally, Berry Wealth Group LP boosted its position in shares of CME Group by 0.4% during the first quarter. Berry Wealth Group LP now owns 13,561 shares of the financial services provider's stock valued at $3,598,000 after buying an additional 49 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on CME shares. Bank of America upped their price target on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Oppenheimer increased their price objective on CME Group from $282.00 to $300.00 and gave the stock an "outperform" rating in a report on Wednesday, June 4th. Morgan Stanley increased their target price on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research report on Thursday, April 24th. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Finally, Barclays lifted their target price on CME Group from $283.00 to $299.00 and gave the stock an "equal weight" rating in a report on Thursday. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, CME Group currently has an average rating of "Hold" and a consensus price target of $260.93.

CME Group Trading Down 0.2%

Shares of CME stock traded down $0.51 during trading on Thursday, hitting $275.13. 635,695 shares of the stock traded hands, compared to its average volume of 2,192,192. The firm has a market capitalization of $99.15 billion, a P/E ratio of 27.68, a price-to-earnings-growth ratio of 3.74 and a beta of 0.44. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm's fifty day moving average price is $276.73 and its 200-day moving average price is $258.73. CME Group Inc. has a 52-week low of $193.17 and a 52-week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the company earned $2.50 EPS. The business's revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were issued a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.82%. CME Group's dividend payout ratio (DPR) is presently 50.30%.

Insider Transactions at CME Group

In related news, Director William R. Shepard bought 256 shares of the company's stock in a transaction that occurred on Wednesday, June 25th. The stock was purchased at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the transaction, the director owned 3,108 shares of the company's stock, valued at approximately $863,651.04. This trade represents a 25.43% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,400 shares of company stock worth $3,680,610 in the last three months. Company insiders own 0.30% of the company's stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.